Jianmei Kochling

Title: Jianmei Kochling: Innovator in Pharmaceutical Applications

Introduction

Jianmei Kochling is a notable inventor based in Wellesley, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit glucosylceramide synthase. Her work is essential for advancing treatments for various diseases.

Latest Patents

Kochling holds a patent for "Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase." This patent describes the hemitartrate salt of a compound represented by a specific structural formula. The invention may be utilized in pharmaceutical applications, and it details particular single crystalline forms characterized by various properties and physical measurements. Additionally, the patent discusses methods for producing crystalline Formula (I) Hemitartrate and its use in lowering glycosphingolipid concentrations in subjects to treat a number of diseases. Pharmaceutical compositions related to this invention are also described.

Career Highlights

Kochling's career is marked by her innovative work at Genzyme Corporation, where she has focused on pharmaceutical research and development. Her expertise in the field has led to advancements that benefit patients and healthcare providers alike.

Collaborations

Throughout her career, Kochling has collaborated with talented individuals such as Hanlan Liu and Chris Willis. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Jianmei Kochling's contributions to pharmaceutical science through her patent and collaborative efforts highlight her role as a key innovator in the industry. Her work continues to pave the way for new treatments and advancements in healthcare.